Intrinsic Value of S&P & Nasdaq Contact Us

Cabaletta Bio, Inc. CABA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.33
+400.9%

Stock Statistics — CABA

Cabaletta Bio, Inc. (CABA) has a market capitalization of $313.82M and trades at $3.26. The 52-week range is 0.986-3.78.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2, Earnings Per Share (EPS) of $-1.64.

The stock has a beta of 3.29, operates in the Healthcare sector.

Trading Data
Current Price$3.26
52-Week Range0.986-3.78
Volume1.41M
Avg Volume (30D)3.07M
Market Cap$313.82M
Beta (1Y)3.29
Company
IPO Date2019-10-25
Employees161
CEOSteven A. Nichtberger
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS12674W1099
CUSIP12674W109
Income (Latest Year)
Gross Profit$-1.65M
EBITDA$-170.6M
Operating Income$-172.24M
Net Income$-167.86M
EPS$-1.64
EPS Diluted$-1.64
Shares Outstanding$102.26M
Balance Sheet (Latest Year)
Total Assets$165.08M
Current Assets$138.87M
Cash & ST Investments$133.6M
Total Liabilities$53.03M
Total Debt$27.1M
Net Debt$-55.88M
Total Equity$112.05M
Debt / Equity0.24
Valuation Ratios
P/E Ratio-2
P/B Ratio2.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message